Abstract
We scored oral mucositis and gut toxicity and measured sugar permeability testing among 56 recipients of a haematopoietic stem cell transplant (HSCT) given myeloablative conditioning with idarubicin, cyclophosphamide and TBI, and a group of 18 patients given cytotoxic chemotherapy for newly diagnosed acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS). Gut integrity was already disturbed in the AML/MDS group as measured by the lactulose/rhamnose ratio (L/R ratio=0.09) before therapy and was severely perturbed (L/R ratio >0.13) for a month after HSCT. Oral mucositis and to a lesser extent gut toxicity was only significantly correlated with disturbed permeability in the transplant group. The data suggest that sugar permeability, oral mucositis and gut toxicity measure different features of mucosal damage after intensive cytotoxic therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bjarnason I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581
Donnelly JP, Muus P, Schattenberg A, de-Witte T, Horrevorts A, DePauw BE (1992) A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 9:409–413
Jansen G, Muskiet FAJ, Schierbeek H, Berger R, Van melle G (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivates, preceded by a simple and rapid prepurification method. Clinica Chimica Acta 157:277–294
Johansson JE, Ekman T (1997) Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings. Bone Marrow Transplant 19:921–925
Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci Colch 92:385–389
Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypolplasia in crypts of the small intestine in humans. Gut 47:632–637
Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE (1993) Intestinal permeability and function in patients infected with human immunodeficiency virus: a comparison with celiac disease. Scand J Gastroenterol 28:573–580
Menzies IS (1984) Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, Heller R (eds) Intestinal absorption and secretion. MTP Press, Lancaster, p 527
Muus P, Donnelly P, Schattenberg A, Linssen P, Minderman H, Dompeling E. de-Witte T (1993) Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent. Semin Oncol 20:47–52
Nitenberg G, Raynard B (2000) Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34:137–168
Parrilli G, Iaffaioli RV, Martorano M, Cuomo R, Tafuto S, Zampino MG, Budillon G, Bianco AR (1989) Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 49:3689–3691
Parulekar W, Mackenzie R, Bjarnason G, Jordan RC (1998) Scoring oral mucositis. Oral Oncol 34:63–71
Rapoport AP, Miller Watelet LF, Linder T, Rberly S, Raubertas RF, Lipp J, Duerst R, Abboud CN, Constine L, Andrews J, Etter MA, Spear L, Powley E, Packman CH, Rowe JM, Schwertschlag U, Bedrosian C, Liesveld JI (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 17:2446–2453
Schaap N, Schattenberg A, Bar B, Preijers F, Geurts van Kessel A, van der Maazen R, De Boo T, De Witte T (1997) Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 98:750–759
Sundstrom GM, Wahlin A, Nordin-Andersson I, Suhr OB (1998) Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol 61:250–254
Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, Fraser CJ, Scarffe JH (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue. Br J Haematol 110:299
Acknowledgements
The authors would like to thank M. Balvers for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blijlevens, N.M.A., van’t Land, B., Donnelly, J.P. et al. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 12, 227–233 (2004). https://doi.org/10.1007/s00520-003-0572-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-003-0572-3